Correlation of Fischer’s Ratio with Liver Fibrosis in Naive Chronic Hepatitis B Patients without Comorbidities
Keywords:Hepatitis B, Fisher's ratio, Liver Fibrosis, hepatitis
Hepatitis B virus infection is one of the most common health problems in the world. 20% Chronic hepatitis B can can change into liver fibrosis. The liver is the center of the body's Amino Acids metabolism. Amino acid changes can occur due to impaired liver function. Fisher's ratio (BCAA/AAA) has become one of the sign of liver fibrosis. This study wanted to find a relationship between Fischer Ratio values and liver fibrosis in naive chronic hepatitis B patients without comorbidities.
The research was conducted from October 2020-May 2021 at DR. Moewardi Hospital, Surakarta, Indonesia. Subjects were naive chronic hepatitis B patients without comorbidities with a minimum age of 30 years. The study used a cross-sectional method. Fischer Ratio values were assessed by spectrophotometry and liver fibrosis was assessed by transient elastography (fibroscan). A correlation test was conducted to determine the relationship between variables.
20 patients were included in the study. The average age of the research subjects was 47 ± 10 years. The average Fisher's ratio value was 2.83 ± 1.16 and the average fibroscan value was 17.31 ± 18.50 kPa. Ratio Fischer had a correlation with liver fibrosis with r= - 0.571 (p=0.004).
Ratio Fischer has a negative correlation with liver fibrosis in naive chronic hepatitis B patients without comorbidities.
Huang DQ, Lim SG. Hepatitis B: Who to treat? A critical review of international guidelines. Liver Int. 2020 Feb;40(S1):5–14.
Asdie AH, Wiyono P, Rahardjo P. Harrison Prinsip-prinsip ilmu penyakit dalam. Jakarta: EGC; 2012.
Parikh P, Ryan JD, Tsochatzis EA. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Ann Transl Med. 2017 Feb;5(3):40–40.
Chang M-L, Yang S-S. Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology. Cells. 2019 Nov 12;8(11):1423.
Enomoto H, Sakai Y, Aizawa N, Iwata Y, Tanaka H, Ikeda N, et al. Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices. Annals of Hepatology. 2013 May;12(3):471–8.
de Lédinghen V, Vergniol J. Transient elastography for the diagnosis of liver fibrosis. Expert Review of Medical Devices. 2010 Nov;7(6):811–23.
Satyadi ., Nusi IA, Setiawan PB, Purbayu H, Sugihartono T, Maimunah U, et al. Transient Elastography as Non-Invasive Examination of Hepatic Fibrosis: In: Proceedings of Surabaya International Physiology Seminar [Internet]. Jawa Timur, Indonesia: SCITEPRESS - Science and Technology Publications; 2017 [cited 2020 Aug 22]. p. 426–30. Available from: http://www.scitepress.org/DigitalLibrary/Link.aspx?doi=10.5220/0007340104260430
Ishikawa T, Imai M, Ko M, Sato H, Nozawa Y, Sano T, et al. Correlation between plasma amino acid profiles and the various stages of hepatitis B infection. 2012 Febt 31:2045–52.
Nefyodov II, Karakosh AJ, Alufaini MA, Karavay PA, Karavay NL. Amino Acids and their Derivatives in Pathogenesis and Treatment of Liver Diseases. Grubovic RM, editor. JHOR. 2019 Dec 4;3(3):1–8.
Wright G, Noiret L, Olde Damink SWM, Jalan R. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies: Interorgan ammonia metabolism in liver failure. Liver International. 2011 Feb;31(2):163–75.
Tessari P, Vettore M, Millioni R, Puricelli L, Orlando R. Effect of liver cirrhosis on phenylalanine and tyrosine metabolism: Current Opinion in Clinical Nutrition and Metabolic Care. 2010 Jan;13(1):81–6.
Aliu E, Kanungo S, Arnold GL. Amino acid disorders. Ann Transl Med. 2018 Dec;6(24):471–471.
Ling L, Zheng D, Zhang Z, Xie W, Huang Y, Chen Z, et al. Effect of HBx on inflammation and mitochondrial oxidative stress in mouse hepatocytes. Oncol Lett [Internet]. 2020 Feb 17 [cited 2020 Jul 11]; Available from: http://www.spandidos-publications.com/10.3892/ol.2020.11404
How to Cite
Copyright (c) 2022 Mohammad Rilwanu Rafsanjani, Triyanta Yuli Pramana, Arifin
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
- Papers must be submitted on the understanding that they have not been published elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal published by any other publisher.
- It is also the authors responsibility to ensure that the articles emanating from a particular source are submitted with the necessary approval.
- The authors warrant that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required.
- The authors ensure that all the references carefully and they are accurate in the text as well as in the list of references (and vice versa).
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.